Antimicrobial Peptide CATH-2 Attenuates Avian Pathogenic E. coli-Induced Inflammatory Response via NF-κB/NLRP3/MAPK Pathway and Lysosomal Dysfunction in Macrophages
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms252312572 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Yating Xu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Joint International Research Laboratory of Animal Health and Animal Food Safety, College of Veterinary Medicine, Southwest University, Chongqing 4007…. Hauptthemen laut MEDLINE: NLR Family, Pyrin Domain-Containing 3 Protein, NF-kappa B, Lysosomes, Escherichia coli Infections. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, National Center of Technology Innovation for pigs, Chongqing Science and Technology Commission.
Abstract (Originalsprache)
Cathelicidins have anti-inflammatory activity and chicken cathelicidin-2 (CATH-2) has shown to modulate immune response, but the underlying mechanism of its anti-inflammation is still unclear. Therefore, in this study, we investigated the anti-inflammatory activity of CATH-2 on murine peritoneal macrophages during avian pathogenic E. coli (APEC) infection. The results showed that CATH-2 priming significantly reduced the production of IL-1β, IL-6, IL-1α, and IL-12. In addition, CATH-2 significantly attenuated APEC-induced caspase-1 activation and the formation of an adaptor (ASC) of NLRP3 inflammasome, indicating that CATH-2 inhibits APEC-induced NLRP3 inflammasome activation. Furthermore, CATH-2 remarkably inhibited NF-κB and MAPK signaling pathways activation. Moreover, CATH-2 significantly inhibited mRNA expression of cathepsin B and inhibited lysosomal acidification, demonstrating that CATH-2 disrupts lysosomal function. In addition, promoting lysosomal acidification using ML-SA1 hampered the anti-inflammatory effect of CATH-2 on APEC-infected cells. In conclusion, our study reveals that CATH-2 inhibits APEC-induced inflammation via the NF-κB/NLRP3/MAPK pathway through the dysfunction of lysosome.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Joint International Research Laboratory of Animal Health and Animal Food Safety, College of Veterinary Medicine, Southwest University, Chongqing 400715, China.
- National Center of Technology Innovation for Pigs, Chongqing 402460, China.
- Division of Infectious Diseases and Geographic Medicine, Department of Medicine, Stanford University, Stanford, CA 94305, USA.
ORCID-Profile: Sha Jiang
Förderung
- National Natural Science Foundation of China
- National Center of Technology Innovation for pigs
- Chongqing Science and Technology Commission
- Chongqing Modern Agricultural Industry Technology System
- Graduate Research Innovation Project of Southwest University
Zitieren
APA
Xu, Y., Xu, L., Zhang, T., Tian, H., Lu, Y., Jiang, S., Cao, X., Li, Z., Hu, X., Fang, R., & Peng, L. (2024). Antimicrobial Peptide CATH-2 Attenuates Avian Pathogenic E. coli-Induced Inflammatory Response via NF-κB/NLRP3/MAPK Pathway and Lysosomal Dysfunction in Macrophages. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252312572
Vancouver
Xu Y, Xu L, Zhang T, Tian H, Lu Y, Jiang S, et al. Antimicrobial Peptide CATH-2 Attenuates Avian Pathogenic E. coli-Induced Inflammatory Response via NF-κB/NLRP3/MAPK Pathway and Lysosomal Dysfunction in Macrophages. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252312572
BibTeX
@article{Xu2024,
author = {Xu, Yating and Xu, Liuyi and Zhang, Tingting and Tian, Hongliang and Lu, Yi and Jiang, Sha and Cao, Xuefeng and Li, Zhiwei and Hu, Xiaoxiang and Fang, Rendong and Peng, Lianci},
title = {Antimicrobial Peptide CATH-2 Attenuates Avian Pathogenic E. coli-Induced Inflammatory Response via NF-κB/NLRP3/MAPK Pathway and Lysosomal Dysfunction in Macrophages},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms252312572}
}
EUVIMED